Case report: dual pathology of LMX1B-associated nephropathy and iga nephropathy in a middle-aged woman
Abstract
Background: Proteinuria is a common manifestation of glomerular disease. Advances in genetic testing have improved recognition of hereditary nephropathies such as LMX1B-associated nephropathy. Coexistence with immune-mediated glomerulonephritis is exceptionally rare.
Case report: We describe a 58-year-old woman with a history of hypertension, type 2 diabetes mellitus, hyperlipidemia, and prior pulmonary embolism who presented with persistent proteinuria. Urinary protein-to-creatinine ratios ranged from 1679 to 3944 mg/g, while renal function remained preserved (estimated GFR 69-103 mL/min/1.73 m²). Genetic testing identified a pathogenic LMX1B mutation consistent with nail-patella syndrome, along with variants of uncertain significance in CYP11B1, ABCC8, and PLG. Kidney biopsy revealed IgA nephropathy with mesangial IgA deposition and ultrastructural findings of podocyte myelinosomes, characteristic of LMX1B-associated nephropathy. Chronicity was minimal (3 of 23 glomeruli globally sclerotic, no segmental sclerosis, and no interstitial fibrosis). Management included renin-angiotensin system blockade and metabolic optimization.
Conclusion: This case illustrates the diagnostic complexity of dual glomerular pathology and underscores the importance of integrating genetic testing with histopathology in patients with atypical proteinuria.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.